What is the current size and annual growth rate of the verluma market?
The verluma market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, increasing demand for imaging diagnostic procedures, growing geriatric population, increasing drug approvals, and growing healthcare infrastructure.
The verluma market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising number of clinical trials, expansion of insurance coverage, increasing incidence of mental health disorders, growing prevalence of neurological disorders, and expansion of telemedicine services. Major trends in the forecast period include the integration of AI and digital health platforms, advancements in drug delivery technologies, advancements in genetic research, technological advancements in drug formulation, and the development of long-acting formulations.
Get Your Free Sample of The Global Verluma Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20430&type=smp
Which major factors have contributed to the expansion of the verluma market?
The increasing incidence of cancer is expected to propel the growth of the verluma market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and potentially spread to other body parts through the blood and lymph systems. The rising cancer incidence is due to aging populations, lifestyle changes, and globalization of risk factors. Verluma is a therapeutic device that uses advanced technology, such as electromagnetic fields or other non-invasive methods, to potentially assist in cancer treatment by targeting and disrupting cancer cell growth, promoting healing, and improving the body’s response to other therapies. For instance, according to the American Cancer Society Facts and Figures, a US-based professional organization, in 2024, over 2 million new cancer cases are expected to be diagnosed in the US, compared to the 1.9 million new cancer cases diagnosed in 2023. Therefore, the increasing incidence of cancer is driving the growth of verluma market.
How is the verluma market segmented?
The verluma market covered in this report is segmented –
1) By Indication: Cancer; Non-Cancer
2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
3) By End User: Adult; Geriatric
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/verluma-global-market-report
Who are the top competitors in the verluma market?
Major companies operating in the verluma market are Boehringer Ingelheim International GmbH
Which key trends are expected to influence the verluma market in the coming years?
Which regional trends are influencing the verluma market, and which area dominates the industry?
North America was the largest region in the verluma market in 2024. The regions covered in the verluma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Verluma Market Report 2025 Offer?
The verluma market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Verluma is a radiolabeled monoclonal antibody fragment used in nuclear medicine to target carcinoembryonic antigen (CEA), a protein often overexpressed in cancerous tumors. It helps detect and stage cancers, such as colorectal cancer, by binding to CEA-expressing tumor cells, allowing visualization through imaging techniques like SPECT.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20430
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
